Texas Back Institute 

Degenerative Disc Disease

• Comparison of Two-Level versus One-Level Total Disc Replacement: Results from a Prospective FDA-Regulated Trial August 2008
  
  Jack E. Zigler, Donna D. Ohnmeiss
• The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment January 2008
  
  Scott L. Blumenthal, Richard D. Guyer, F. Geisler, Paul C. McAfee, J. Regan
• Two- to Three-Year Follow-Up of ProDisc-L: Results from a Prospective Randomized Trial of Arthroplasty versus Fusion October 2007
  
  Jack E. Zigler, Barton L. Sachs, Ralph F. Rashbaum, Donna D. Ohnmeiss
• An Economic Model of One-Level Lumbar Arthroplasty versus Fusion October 2007
  
  Richard D. Guyer, Scott G. Tromanhauser, John J. Regan
• Complications of Lumbar Artificial Disc Replacement Compared to Fusion: Results from the Prospective, Randomized, Multicenter U.S. Food and Drug Administration Investigational Device Exemption Study of the Charité Artificial Disc April 2007
  
  R. T. Holt, M. E. Majd, J. E. Isaza, Scott L. Blumenthal, Paul C. McAfee, Richard D. Guyer, et al.
• Lumbar Spine Arthroplasty Using the ProDisc II November 2004
  
  Jack E. Zigler